论文部分内容阅读
目的探讨经过介入治疗后,不稳定型心绞痛(UAP)患者超敏C反应蛋白(hs-CRP)水平的变化,并分析其对患者预后的影响。方法 2010年01月至2011年07月期间,郑州市中心医院诊治的60例不稳定型心绞痛患者,经皮冠状动脉介入治疗,检测患者术前、术后的超敏C反应蛋白水平。结果与术前超敏C反应蛋白水平(4.54±0.37)mg/L相比,术后超敏C反应蛋白的水平(8.84±1.32)mg/L明显升高,P<0.05,差异有统计学意义。结论经皮冠状动脉介入治疗后,进行超敏C反应蛋白水平的检测,提高术后对心肌损伤的灵敏度的检测,有助于术后的监测治疗,以及判断患者的预后,值得临床广泛推广。
Objective To investigate the changes of hs-CRP in patients with unstable angina pectoris (UAP) after interventional therapy, and to analyze the influence on the prognosis of patients. Methods From January 2010 to July 2011, 60 patients with unstable angina pectoris treated by Zhengzhou Central Hospital were treated with percutaneous coronary intervention to detect preoperative and postoperative high-sensitivity C-reactive protein levels. Results Compared with preoperative hypersensitive C-reactive protein (4.54 ± 0.37) mg / L, the level of postoperative hypersensitive C-reactive protein (8.84 ± 1.32) mg / L was significantly increased, P <0.05, the difference was statistically significant significance. Conclusion Percutaneous coronary intervention after the detection of high-sensitivity C-reactive protein to improve postoperative detection of myocardial damage sensitivity, to help postoperative monitoring and treatment, and to determine the prognosis of patients, it is widely recommended in the clinic.